These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15041044)

  • 41. IgA anti-dsDNA antibodies in systemic lupus erythematosus: occurrence, incidence and association with clinical and laboratory variables of disease activity.
    Miltenburg AM; Roos A; Slegtenhorst L; Daha MR; Breedveld FC
    J Rheumatol; 1993 Jan; 20(1):53-8. PubMed ID: 8441166
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus.
    Haddouk S; Marzouk S; Jallouli M; Fourati H; Frigui M; Hmida YB; Koubaa F; Sellami W; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H
    Rheumatology (Oxford); 2009 Aug; 48(8):953-7. PubMed ID: 19502474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of anti-ribosomal P protein immunoassay in Japanese patients with connective tissue diseases: comparison with an indirect immunofluorescence assay.
    Muro Y; Sugiura K; Morita Y; Tomita Y
    Scand J Rheumatol; 2009; 38(6):460-3. PubMed ID: 19922022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The antichromatin antibodies can be useful as a diagnostic tool and disease activity marker of systemic lupus erythematosus in Koreans.
    Kim HA; Jeon JY; Choi GS; Sung JM; Kim MJ; Yun JM; Suh CH
    Clin Immunol; 2008 Aug; 128(2):277-83. PubMed ID: 18504161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serological and clinical characterization of anti-dsDNA and anti-PM/Scl double-positive patients.
    Mahler M; Greidinger EL; Szmyrka M; Kromminga A; Fritzler MJ
    Ann N Y Acad Sci; 2007 Aug; 1109():311-21. PubMed ID: 17785320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of antinucleosome antibodies in Tunisian systemic lupus erythematosus patients.
    Haddouk S; Ben Ayed M; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H
    Clin Rheumatol; 2005 Jun; 24(3):219-22. PubMed ID: 15940555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
    Al Arfaj AS; Chowdhary AR; Khalil N; Ali R
    Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new oligonucleotide-based ELISA for the detection of anti-double-stranded DNA antibodies.
    Radice A; Sinico RA
    Autoimmunity; 2006 Mar; 39(2):113-9. PubMed ID: 16698667
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Determination of anti dsDNA antibodies by immunofluorescence using Crithidia luciliae. I--Diagnostic and prognostic value in systemic lupus erythematosus. Comparison with the Farr radioimmunoassay].
    Borda-Iriarte O; Meyer O; Cyna J; Haïm T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1984 Apr; 51(4):185-91. PubMed ID: 6374861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nucleosomes in the pathogenesis of systemic lupus erythematosus.
    Koutouzov S; Jeronimo AL; Campos H; Amoura Z
    Rheum Dis Clin North Am; 2004 Aug; 30(3):529-58, ix. PubMed ID: 15261340
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
    Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
    Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
    Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
    J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Levels of anti-nDNA using immunofluorescence on Crithidia luciliae. II. Prognostic value of complement-fixing anti-nDNA. Longitudinal study of 16 lupus disorders].
    Meyer O; Borda-Iriarte O; Cyna J; Haïm T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1984 May; 51(5):243-9. PubMed ID: 6377460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of cut-off value for autoantibodies against double-stranded DNA-complexed nucleosomes based on enzyme linked immunosorbent assay].
    Ohnuma K; Hayashi N; Fukuzumi N; Saito A; Tanaka M; Kumagai S; Kawano S
    Rinsho Byori; 2014 Mar; 62(3):223-30. PubMed ID: 24800496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specificity of the hydrochloric-acid-modified Crithidia luciliae immunofluorescence assay for detection of antibody to native DNA.
    Henderson T; Medsger TA; Sontheimer RD; Harmon CE; Deng JS
    Diagn Clin Immunol; 1987; 5(1):20-4. PubMed ID: 3297382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.
    Zandman-Goddard G; Blank M; Langevitz P; Slutsky L; Pras M; Levy Y; Shovman O; Witte T; Doria A; Rovensky J; Shoenfeld Y
    Ann Rheum Dis; 2005 Dec; 64(12):1698-702. PubMed ID: 16014675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.